The FDA's Decision to Ban Compounds: What You Need to Know An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica Fresh from the biotech pipeline: record breaking FDA approvals Nature Biotechnology FDA Grants Accelerated Approval to Ponatinib Plus Chemotherapy in First Line Ph+ ALL AJMC BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law